| Literature DB >> 29317985 |
Yu-Chen Cheng1, Jer-Ming Sheen1, Wen Long Hu1,2,3, Yu-Chiang Hung1,4.
Abstract
Good nutrition could maintain health and life. Polyphenols are common nutrient mainly derived from fruits, vegetables, tea, coffee, cocoa, mushrooms, beverages, and traditional medicinal herbs. They are potential substances against oxidative-related diseases, for example, cardiovascular disease, specifically, atherosclerosis-related ischemic heart disease and stroke, which are health and economic problems recognized worldwide. In this study, we reviewed the risk factors for atherosclerosis, including hypertension, diabetes mellitus, hyperlipidemia, obesity, and cigarette smoking as well as the antioxidative activity of polyphenols, which could prevent the pathology of atherosclerosis, including endothelial dysfunction, low-density lipoprotein oxidation, vascular smooth muscle cell proliferation, inflammatory process by monocytes, macrophages or T lymphocytes, and platelet aggregation. The strong radical-scavenging properties of polyphenols would exhibit antioxidative and anti-inflammation effects. Polyphenols reduce ROS production by inhibiting oxidases, reducing the production of superoxide, inhibiting OxLDL formation, suppressing VSMC proliferation and migration, reducing platelet aggregation, and improving mitochondrial oxidative stress. Polyphenol consumption also inhibits the development of hypertension, diabetes mellitus, hyperlipidemia, and obesity. Despite the numerous in vivo and in vitro studies, more advanced clinical trials are necessary to confirm the efficacy of polyphenols in the treatment of atherosclerosis-related vascular diseases.Entities:
Mesh:
Substances:
Year: 2017 PMID: 29317985 PMCID: PMC5727797 DOI: 10.1155/2017/8526438
Source DB: PubMed Journal: Oxid Med Cell Longev ISSN: 1942-0994 Impact factor: 6.543
Figure 1Effects of polyphenols in endothelial cells and smooth muscle cells. AA: arachidonic acid; COX: cyclooxygenase; PGE2/H2/I2: prostaglandin E2/H2/I2; TXA2: thromboxane A2; eNOS: endothelial nitric oxide synthase; NO: nitric oxide; ET-1: endothelin-1; ETA/B: endothelin A/B receptor; LDL: low-density lipoprotein; PDGF: platelet-derived growth factor; NOX: NADPH oxidase; SOD: superoxidase dismutase; H2O2: hydrogen peroxide; GTP: guanosine triphosphate; sGC: soluble guanylate cyclase; cGMP: cyclic guanosine monophosphate; AngII: angiotensin II; AT1: angiotensin II receptor type 1; PPARγ: peroxisome proliferator-activated receptor γ; NF-κB: nuclear factor kappa B.
Figure 2Effects of polyphenols in LDL and inflammatory process with monocytes and macrophages. ROS: reactive oxygen species; LDL: low-density lipoprotein; OxLDL: oxidized low-density lipoprotein; MCP-1: monocyte chemoattractant protein 1; iNOS: inducible nitric oxide synthase; TNF-α: tumor necrosis factor-α; IL-1: interleukin-1; IL-6: interleukin-6; PPARγ: peroxisome proliferator-activated receptor γ; NF-κB: nuclear factor kappa B.
Figure 3Effects of polyphenols in platelets. ADP: adenosine diphosphate; NO: nitric oxide; TXA2: thromboxane A2; GP1b: glycoprotein Ib; GPIIb/IIIa: glycoprotein IIb/IIIa; vWF: Von Willebrand factor; PDGF: platelet-derived growth factor.
Figure 4Risk factors and pathology process of atherosclerosis leading to ischemic heart disease or ischemic stroke.
Mechanisms of polyphenols in preventing atherosclerosis formation.
| Pathology of atherosclerosis | Polyphenols/polyphenol-rich food | Preventing mechanism | Reference |
|---|---|---|---|
| Endothelial dysfunction | Hydroxytyrosol and EVOO polyphenol extract | ↑ eNOS phosphorylation, ↑ NO | [ |
| High- versus low-dose flavonoid dark chocolate (213 mg versus 46 mg procyanidins) | ↑ endothelium-dependent flow-mediated dilation of the brachial artery | [ | |
| Red wines and grapes | ↑ NO activity | [ | |
|
| |||
| OxLDL | Red wine | ⊝ copper-catalyzed oxidation of LDL | [ |
| (−)-Epicatechin gallate-enriched | ↓ OxLDL-dependent apoptosis | [ | |
| Green tea catechins | Incorporated into LDL particles in nonconjugated forms | [ | |
|
| |||
| VSMC proliferation | Red wine | ⊝ inhibition of PDGF | [ |
| Pterostilbene, polyphenol compound in blueberries | ↓ VSMC migration | [ | |
| Resveratrol | ↑ serum BDNF concentrations | [ | |
| Curcumin | ↓ expression of p47phox | [ | |
|
| |||
| Monocyte/macrophage and T lymphocytes inflammatory process | Tea flavonoids (theaflavin digallate, theaflavin, epigallocatechin gallate, epigallocatechin, and gallic acid) | ↓ cell-mediated LDL oxidation | [ |
| Pomegranate juice | ⊝ acrolein increases macrophage lipid accumulation and alters the gut microbiota composition | [ | |
| Ellagic acid | ⊝ tautomerase activity of human macrophage MIF | [ | |
| Polyphenol-rich extract | ↓ MCP-1 | [ | |
| Resveratrol, isorhamnetin, curcumin, vanillic acid, and specific (poly)phenol mixtures | ↓ IL-6, interferon- | [ | |
|
| |||
| Platelet aggregation | Pomegranate juice or the polyphenol-rich extract from pomegranate fruit | ⊝ collagen- and arachidonic acid-induced platelet aggregation | [ |
| Cocoa and dark chocolate | ↓ ADP-, adrenaline- and, epinephrine-induced GPIIb/IIIa membrane activation | [ | |
↑: increase; ↓: decrease; ↔: no change; ⊝: inhibit; ⊕: promote. EVOO: extra virgin olive oil; eNOS: endothelial nitric oxide synthase; NO: nitric oxide; ET-1: endothelin-1; LDL: low-density lipoprotein; ROS: reactive oxygen species; Erk: extracellular-signal-regulated kinase; PDGF: platelet-derived growth factor; VSMCs: vascular smooth muscle cells; MMP-2: matrix metalloproteinase-2; BDNF: brain-derived neurotrophic factor; MIF: migration inhibitory factor; MCP-1: monocyte chemoattractant protein 1; H2O2: hydrogen peroxide; ADP: adenosine diphosphate; GPIIb/IIIa: glycoprotein IIb/IIIa; PLA2: phospholipase A2; COX: cyclooxygenase; 8-iso-PGF2α: 8-isoprostane-prostaglandin F2α; NOX2: NADPH oxidase 2.